BackSenti Biosciences Overview

Senti Biosciences Total Liabilities

Track Senti Biosciences's total liabilities ($36M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$35.68M
↓ 20.58% YoYΔ $-9.24M vs prior year quarter

Peer average

Loading

Senti Biosciences Total Liabilities History

Loading

Senti Biosciences vs. peers: Total Liabilities Comparison

Loading

Senti Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Senti Biosciences (SNTI) FAQ

Senti Biosciences (SNTI) currently reports a total liabilities of $36M as of March 2026. That compares with $45M in the prior-year period — down 20.6% year over year. Use the charts on this page to explore Senti Biosciences's total liabilities history and peer comparisons.

Senti Biosciences's total liabilities decreased from $45M to $36M — a 20.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Senti Biosciences reported $36M in total liabilities as of March 2026. That compares with $45M in the prior-year period — down 20.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Senti Biosciences, and consider following SNTI for alerts when major investors trade the stock.